You are viewing the site in preview mode

Skip to main content


Fig. 3 | BMC Health Services Research

Fig. 3

From: The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries

Fig. 3

One-way sensitivity analyses. *Patients prescribed 320/9 μg or 500 μg inhalers, **Patients prescribed 160/4.5 μg or 250 μg inhalers, ***Patients prescribed 80/4.5 μg or 100 μg inhalers. Sensitivity analyses for a) Spain, b) Sweden and c) the UK. Parameters were varied as described in the Methods section. Results are displayed from the greatest change to the least change for each country. Values are subject to rounding

Back to article page